SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-006301
Filing Date
2024-03-01
Accepted
2024-03-01 16:30:54
Documents
17
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A arch20230930_10ka.htm   iXBRL 10-K/A 154069
2 EXHIBIT 31.1 ex_631800.htm EX-31.1 10797
3 EXHIBIT 31.2 ex_631801.htm EX-31.2 10706
  Complete submission text file 0001437749-24-006301.txt   389127

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arch-20230930.xsd EX-101.SCH 3408
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230930_def.xml EX-101.DEF 16689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230930_lab.xml EX-101.LAB 22743
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230930_pre.xml EX-101.PRE 17619
18 EXTRACTED XBRL INSTANCE DOCUMENT arch20230930_10ka_htm.xml XML 6242
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-54986 | Film No.: 24710427
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)